Venus Remedies gets CII’s Responsible Export Organisation certification

Venus Remedies has emerged as the first pharma company in India to have received the Responsible Export Organisation (REO) certification from the Confederation of Indian Industry (CII) following an elaborate screening and assessment process. It is among the seven Indian companies across diverse sectors which have been granted the CII’s REO certification this year, Venus Remedies said in a statement.

Hailing the achievement, Saransh Chaudhary, President, Global Critical Care, Venus Remedies, and CEO, Venus Medicine Research Centre, said in the statement, “The REO certification from the CII will provide further impetus to our export business and give us an edge in global markets. Exports account for 70 per cent of our revenue, and this certification will enable us to go from strength to strength to emerge as an export powerhouse.”

With a 360-degree approach to evaluate companies’ export competency, the stringent criteria for the certification covered various heads like leadership and governance, people skills and competencies, operations management, supply chain, customer focus, financial management, resource management, safety and other performance metrics. Apart from self-assessment and audits, the certification also took into consideration feedback from all stakeholders involved in product development and supply chain, right from the management to vendors and customers, the statement further said.